Search results for "biotech" in Articles / App Notes
Article
The Tide Stays High
Equity markets’ appetite for public offerings from emerging bio/pharmaceutical companies had significantly diminished: valuations of emerging bio/pharma companies, as measured by the NASDAQ Biotechnol…
Article
Biosimilars to Drive Modern Manufacturing Approaches
By Jill Wechsler
As more biosimilars gain market approval in the United States, and manufacturers launch additional programs to develop competitive biotech therapies, regulatory authorities and in…
Article
Generating a Fully Processed Antibody
The authors outline cell-line development and process scale-up for an antibody program in which the antibody requires additional processing by a site-specific enzyme for correct functionality.
B…
Article
Managing Biomanufacturing Capacity Expectations
Wyss estimates that almost all biotech companies that have several products on the market use a mixed approach to manufacturing, but most companies keep the number of CMOs that they work with to a min…
Article
A Q&A on Bioprocessing Trends and Technologies at INTERPHEX 2016
One sign of progress was the opening of a JHL Biotech flexible manufacturing facility in Wuhan, China on May 10, 2016, for the manufacture of biosimilars and monoclonal antibodies (mAbs). The facility…
Article
Designing a Biomanufacturing Facility Incorporating Single-Use Technologies
For example, for a small biotech that was particularly concerned about reducing capital expenditure, the ultimate recommendation was to buy-in ready-made buffer and media in single-use liquid delivery…
Article
Platform Approach Speeds Process Development
Recently, miniaturized disposable small-scale bioreactor systems such as the ambr15 and ambr250 (Sartorius Stedim Biotech) became integral parts of fast-track process development strategies as enablin…
Article
Vaccine Development Faces Urgency and Challenges
GSK, Pfizer, Merck, Johnson & Johnson, and Takeda, as well as several smaller biotech firms, are examining vaccine research portfolios for potential candidates to combat Zika.
Anthony Fauci, direc…
Article
A Risk-Based Genetic Characterization Strategy for Recombinant CHO Cell Lines Used for Clinical and Commercial Applications
Potential applications of new technologies for the characterization of transgenes
As the biotechnology industry continues to mature, so does the ability to understand the processes used to manufact…
Article
KUBio modular biopharm facility built in Germany, assembled in China
Cytiva is supplying a full biopharmaceutical processing solution, known as a KUBio, to JHL Biotech in Wuhan, China. The sixty-two completed modules that make up the factory have completed the journe…